🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Abortion is one of the most common complications of pregnancy. Missed abort...
Status
Recruiting
Location
Aswan University Hospital
Start Date
2025-07-10
Trial ID
NCT07109947
Treatments Being Tested
RATIONALE: Monoclonal antibodies, such as trastuzumab, can block tumor grow...
Status
Completed
Location
Kantonspital Aarau
Start Date
2005-05
Trial ID
NCT00238290
Treatments Being Tested
The goal of this clinical trial is to learn whether letrozole, a hormone th...
Status
Not Yet Recruiting
Location
Cancer Care Hospital and Research Centre Foundation
Start Date
2026-06
Trial ID
NCT07394946
Treatments Being Tested
A retrospective study of de-identified (to preserve patient privacy) patien...
Status
Completed
Location
Pfizer New York
Start Date
2023-09-29
Trial ID
NCT06086340
Treatments Being Tested
A study to compare the safety and efficacy of an aromatase inhibitor in com...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-05-05
Trial ID
NCT01160211
Treatments Being Tested
This research study is evaluating a drug called Palbociclib in combination ...
Status
Completed
Location
University of California, San Francisco
Start Date
2014-01
Trial ID
NCT02040857
Treatments Being Tested
The goal of the randomised controlled study (RCT) is to identify novel stra...
Status
Completed
Location
Herlev Hospitals Fertilitetsklinik
Start Date
2018-09-18
Trial ID
NCT04524026
Treatments Being Tested
Prophylactic use of aromatase inhibitor is effective in decreasing the inci...
Status
Unknown
Location
Mohamed ALI Alabiad
Start Date
2020-06-01
Trial ID
NCT05203562
Treatments Being Tested
Observational investigation of participants who are given neoadjuvant treat...
Status
Not Yet Recruiting
Location
National Institute of Oncolgy
Start Date
2022-03
Trial ID
NCT05131893
AMBRE is a phase III study comparing two standard treatments as initial met...
Status
Active Not Recruiting
Location
Centre Hospitalier Lyon Sud
Start Date
2020-06-11
Trial ID
NCT04158362